Related Experiment Video
Updated: Aug 9, 2026
08:45
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Protein phosphatase 1alpha activity prevents oncogenic transformation
Cathy W Y Liu1, Rui-Hong Wang, Norbert Berndt
1Division of Hematology/Oncology, Childrens Hospital Los Angeles, The University of Southern California Keck School of Medicine, Los Angeles, 90027, USA.
Molecular Carcinogenesis
|March 22, 2006
Summary
Protein phosphatase 1alpha (PP1alpha) activity, when resistant to inhibition, halts cell cycle progression and oncogenic transformation. Constitutively active PP1alpha prevents cancer cell growth by inducing cell cycle arrest or apoptosis.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Cyclin-dependent kinase 2 (Cdk2) regulates cell cycle progression by phosphorylating key proteins.
- Protein phosphatase 1alpha (PP1alpha) activity is inhibited by Cdk2 phosphorylation at Thr320 in late G1 phase.
- The retinoblastoma protein (pRb) pathway is critical for cell cycle control and frequently altered in human cancers.
Purpose of the Study:
- To investigate the role of PP1alpha in regulating oncogenic transformation.
- To determine if PP1alpha can interfere with cancer development pathways.
- To explore the therapeutic potential of modulating PP1alpha activity.
Main Methods:
- Utilized a phosphorylation-resistant PP1alpha mutant (PP1alphaT320A) to mimic constitutively active PP1alpha.
- Assessed focus formation and soft agar colony formation in NIH 3T3 cells transformed with ras/cyclin D1.
- Employed Western blotting to detect caspase-cleaved pRb and observed morphological signs of cell death.
Main Results:
- Constitutively active PP1alphaT320A significantly inhibited focus formation and soft agar colony formation in transformed NIH 3T3 cells.
- Wild-type PP1alpha showed limited effect due to phosphorylation at Thr320.
- Expression of PP1alphaT320A led to cell-cycle arrest and/or apoptosis, evidenced by cleaved pRb and cell death morphology.
Conclusions:
- PP1alpha acts as a crucial regulator of the pRb pathway, capable of overriding oncogenic signaling.
- Constitutively active PP1alpha can suppress cancer cell proliferation and survival.
- Targeting PP1alpha activity represents a potential strategy for cancer therapy.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...